secwatch / observer
8-K filed March 10, 2026, 7:59 PM ET ticker ULBI CIK 0000875657
earnings confidence high sentiment negative materiality 0.75

Ultralife Q4 revenue $48.5M, but operating loss of $10.6M on $12.2M impairment; GAAP EPS ($0.45)

ULTRALIFE CORP

Key facts

Extracted from this filing and checked against the source text.

Earnings Releases SEC 8-K Item 2.02 confidence 0.9

ULTRALIFE CORP reported the fourth quarter ended December 31, 2025 results: revenue $48.5 million, net income ($7.4) million, EPS ($0.45) per basic and diluted share.

Period
the fourth quarter ended December 31, 2025
Revenue
$48.5 million
Net income
($7.4) million
EPS
($0.45) per basic and diluted share
Result
reported results
Exact text from the filing
Ultralife Corporation (NASDAQ: ULBI) reported operating results for the fourth quarter and full year ended December 31, 2025 as follows: Fourth Quarter: ● Sales of $48.5 million compared to $43.9 million for the 2024 fourth quarter ● Gross profit of $12.1 million, or 24.9% of revenue, compared to $10.6 million, or 24.2% of revenue, for the 2024 fourth quarter ● Operating (loss) income of ($10.6) million, which includes a ($12.2) million intangible asset impairment charge and ($1.2) million of one-time costs, compared to $1.5 million for the 2024 fourth quarter ● GAAP EPS of ($0.45), which includes ($0.57) for the intangible asset impairment charge net of the related tax benefits, compared to $0.01 for the 2024 fourth quarter
View on SEC.gov

Browse all earnings releases →

ULTRALIFE CORP filing history →

Source: SEC EDGAR
accession 0001437749-26-007567
Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.